11/12
09:00 am
mynz
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
High
Report
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
10/21
02:11 pm
mynz
Mainz Biomed B.V. GAAP EPS of -$0.49, revenue of $520.77M [Seeking Alpha]
Low
Report
Mainz Biomed B.V. GAAP EPS of -$0.49, revenue of $520.77M [Seeking Alpha]
10/21
08:01 am
mynz
Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
Medium
Report
Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
10/8
08:01 am
mynz
Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version
Medium
Report
Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version
10/1
08:01 am
mynz
Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
Medium
Report
Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
9/18
08:01 am
mynz
Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador
Medium
Report
Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador
9/4
04:01 am
mynz
Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert
Medium
Report
Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert